The transcriptional programme of contact-inhibition

Journal of Cellular Biochemistry

Volumn 110, Issue 5, 2010, Pages 1234-1243

  Küppers, Monika ^a   Ittrich, Carina ^b,c   Faust, Dagmar ^a   Dietrich, Cornelia ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Cell cycle regulation; Contact inhibition; Fibroblasts; Gene expression profiling

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CELL ADHESION; CELL COMMUNICATION; CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; COMPUTER PROGRAM; CONTACT INHIBITION; DNA SEQUENCE; FIBROBLAST; GENE FUNCTION; GENETIC TRANSCRIPTION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CONTACT INHIBITION; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; MICE; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77954940556     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22638     Document Type: Article

References (51)

1. Abercrombie M. 1979. Contact inhibition and malignancy. Nature 281:259-262.
2. Afrakhte M, Heldin N-E, Westermark B. 1998. Inhibition of G1 cyclin-dependent kinase activity in cell density-dependent growth arrest in human fibroblasts. Cell Growth Differ 9:983-988. (Pubitemid 29036192)
3. Aoki J, Takio K, Titani K, Utsumi H, Sasaki M, Inoue K. 1991. Neural cell adhesion molecule mediates contact-dependent inhibition of growth of near-diploid mouse fibroblast cell line m5S/1M. J Cell Biol 115:1751-1761. (Pubitemid 21910014)
4. Assoian RK, Yung Y. 2008. A reciprocal relationship between Rb and Skp2. Cell Cycle 7:24-27.
5. Baba M, Hirai S, Yamada-Okabe H, Hamada K, Kobayashi K, Kondo K, Yoshida M, Yamashita A, Kishida T, Nakaigawa N, Nagashima Y, Kubota Y, Yao M, Ohno S. 2003. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of cyclin D1 expression through hypoxia-inducible factor. Oncogene 22:2728-2738.
6. Barath P, Luciakova K, Hodny Z, Li R, Nelson BD. 1999. The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription. Exp Cell Res 248:583-588.
7. Carrano AC, Eytan E, Hershko A, Pagano M. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199. (Pubitemid 129500937)
8. Cheng J, Sun S, Tracy A, Hubbell E, Morris J, Valmeekam V, Kimbrough A, Cline MS, Liu G, Shigeta R, Kulp D, Siani-Rose MA. 2004. Net Affx Gene Ontology Mining Tool: A visual approach for microarray data analysis. Bioinformatics 20:1462-1463.
9. Cobrinik D. 2005. Pocket proteins and cell cycle control. Oncogene 24:2796-2809. (Pubitemid 40638091)
10. Cope LM, Irizarry RA, Jaffee HA, Wu Z, Speed TP. 2004. A benchmark for Affymetrix Gene Chip expression measures. Bioinformatics 20: 323-331. (Pubitemid 38262763)
11. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. 2002. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31:19-20.
12. Del Sal G, Ruaro ME, Philipson L, Schneider C. 1992. The growth arrest-specific gene, gas1, is involved in growth suppression. Cell 70:595-607.
13. Dietrich C, Wallenfang K, Oesch F, Wieser F. 1997. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Oncogene 15:2743-2747. (Pubitemid 27507622)
14. Dietrich C, Faust D, Budt S, Moskwa M, Kunz A, Bock K-W, Oesch F. 2002. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: Involvement of cyclin A. Toxicol Appl Pharmacol 183:117-126.
15. Doi Y, Kawamata H, Ono Y, Fujimori T, Imai Y. 2008. Expression and cellular localization of TSC-22 in normal salivary glands and salivary gland tumors: Implications for tumor cell differentiation. Oncol Rep 19:609-616. (Pubitemid 351330425)
16. Eagle H, Levine E. 1967. Growth regulatory effects of cellular interaction. Nature 213:1102-1106.
17. Ecker K, Hengst L. 2009. Skp2: Caught in the Akt. Nat Cell Biol 11:377-379.
18. Fagotto F, Gumbiner BM. 1996. Cell contact-dependent signaling. Dev Biol 180:445-454.
19. Faust D, Dolado I, Cuadrado A, Oesch F, Weiss C, Nebreda AR, Dietrich C. 2005. p38α MAPK is required for contact inhibition. Oncogene 24:7941-7945.
20. Fielden MR, Brennan R, Gollub J. 2007. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol Sci 99:90-100. (Pubitemid 47250370)
21. Gos M, Miloszewska J, Swoboda P, Trembacz H, Skierski J, Janik P. 2005. Cellular quiescence induced by contact inhibition or serum withdrawal in C3H10T1/2 cells. Cell Prolif 38:107-116. (Pubitemid 40593598)
22. Gupta R, Sarraf P, Brockman JA, Shappell SB, Raftery LA, Willson TM, DuBois RN. 2003. Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22. J Biol Chem 278:7431-7438. (Pubitemid 36800748)
23. Hashiguchi A, Hitachi K, Inui M, Okabayashi K, Asashima M. 2007. TSC-box is essential for nuclear localization and antiproliferative effect of XTSC-22. Dev Growth Differ 49:197-204. (Pubitemid 46452384)
24. Heit I, Wieser R, Herget T, Faust D, Borchert-Stuhlträger M, Oesch F, Dietrich C. 2001. Involvement of PKCd in contact-dependent inhibition of growth in human and murine fibroblasts. Oncogene 20:5143-5154. (Pubitemid 32844043)
25. Hershko DD. 2008. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer 112:1415-1424.
26. Holley RW, Kiernan JA. 1968. "Contact inhibition" of cell division in 3T3 cells. Proc Natl Acad Sci USA 60:300-304.
27. Iida M, Anna CH, Holliday WM, Collins JB, Cunningham ML, Sills RC, Devereux TR. 2005. Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens. Carcinogenesis 26:689-699.
28. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15.
29. Kawamata H, Nakashiro K, Uchida D, Hino S, Ometehara F, Yoshda H, Sato M. 1998. Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br J Cancer 77:71-78.
30. Kawamata H, Omotehara F, Nakashiro K, Uchida D, Hino S, Fujimori T. 2003. Vesnarinone: A differentiation-inducing anti-cancer drug. Anticancer Drugs 14:391-395.
31. Kester HA, Blanchetot C, den Hertog J, van der Saag PT, van der Burg B. 1999. Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. J Biol Chem 274:27439-27447.
32. Kester HA, Ward-van Oostwaard TH, Goumans MJ, van Rooijen MA, van der Saag PT, van der Burg B, Mummery CL. 2000. Expression of TGF-beta stimulated clone-22 (TSC-22) in mouse development and TGF-beta signalling. Dev Dyn 218:563-572.
33. Kim S, Chin K, Gray JW, Bishop M. 2004. A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 101:16251-16256.
34. Malumbres M, Barbacid M. 2005. Mammalian cyclin-dependent kinases. Trends Biochem Sci 30:630-641.
35. Michel C, Roberts RA, Desdouets C, Isaacs KR, Boitier E. 2005. Characterization of an acute molecular marker of nongenotoxic rodent hepatocarcinogenesis by gene expression profiling in a long term clofibric acid study. Chem Res Toxicol 18:611-618.
36. Mittnacht S, Weinberg RA. 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381-393.
37. Nakashiro K, Kawamata H, Hino S, Uchida D, Miwa Y, Hamano H, Omotehara F, Yoshida H, Sato M. 1998. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res 58:549-555.
38. Nakayama KI, Nakayama K. 2005. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol 16:323-333.
39. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
40. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. 1994. p27KIP1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22.
41. Rentsch CA, Cecchini MG, Schwaninger R, Germann M, Markwalder R, Heller M, van der Pluijm G, Thalmann GN, Wetterwald A. 2006. Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer. Int J Cancer 118:899-906. (Pubitemid 43157665)
42. Rutishauser U, Acheson A, Hall AK, Mann DM, Sunshine J. 1988. The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 240:53-57.
43. Shostak KO, Dmitrenko VV, Garifulin OM, Rozumenko VD, Khomenko O, Zozulya YA, Zehetner G, Kavsan VM. 2003. Downregulation of putative tumor suppressor gene TSC-22 inhumanbrain tumors. J Surg Oncol 82:57-64. (Pubitemid 36055491)
44. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
45. Smyth GK, Yang YH, Speed T. 2003. Statistical issues in cDNA microarray data analysis. Methods Mol Biol 224:111-136.
46. Swat A, Dolado I, Rojas JM, Nebreda AR. 2009. Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation. Mol Cell Biol 29:3332-3343.
47. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T, Costa RH. 2005. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 25:10875-10894.
48. INK4 mediates contact inhibition of growth. Oncogene 18:277-281.
49. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F. 2004. J Am Stat Assoc 99:909-917.
50. Yu J, Ershler M, Yu L, Wei M, Hackanson B, Yokohama A, Mitsui T, Liu C, Mao H, Liu S, Liu Z, Trotta R, Liu C, Liu X, Huang K, Visser J, Marcucci G, Plass C, Belyavsky AV, Calligiuri MA. 2009. TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is genetically silenced in large granular lymphocyte leukemia. Blood 113:5558-5567.
51. Zeng Q, Hong W. 2008. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 13:188-192. (Pubitemid 351318373)